{"DataElement":{"publicId":"5654374","version":"1","preferredName":"Squamous Cellular Carcinoma Antigen Tumor Marker Result Less Initial Pathologic Diagnosis Date Calculated Day Value","preferredDefinition":"Time interval from the date of Squamous Cellular Carcinoma Antigen (SCCA) Tumor Marker Result to the date of initial pathologic diagnosis, represented as a calculated number of days.","longName":"5654366v1.0:3008213v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"5654366","version":"1","preferredName":"Laboratory Procedure Tumor Marker Squamous Cell Carcinoma Antigen Outcome Subtraction Diagnosis Time Duration","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations._A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma._Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens._The result of an action._The act of removing a part from the whole._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._The continuum of experience in which events pass from the future through the present to the past._The period of time during which something continues.","longName":"5654364v1.0:2234809v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"5654364","version":"1","preferredName":"Laboratory Procedure Tumor Marker Squamous Cell Carcinoma Antigen Outcome Subtraction Diagnosis Time","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:A substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids. A high level of a tumor marker may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (in ovarian cancer), CA 15-3 (in breast cancer), CEA (in ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (in prostate cancer).:A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.:Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.:The result of an action.:The act of removing a part from the whole.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:The continuum of experience in which events pass from the future through the present to the past.","longName":"5654364v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Antigen","conceptCode":"C268","definition":"Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Subtraction","conceptCode":"C70590","definition":"The act of removing a part from the whole.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Time","conceptCode":"C25207","definition":"The continuum of experience in which events pass from the future through the present to the past.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"47DE3C27-C0DE-795B-E053-F662850AC379","latestVersionIndicator":"Yes","beginDate":"2017-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-06","modifiedBy":"ONEDATA","dateModified":"2017-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234809","version":"1","preferredName":"Duration","preferredDefinition":"The period of time during which something continues.","longName":"C25330","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Duration","conceptCode":"C25330","definition":"The period of time during which something continues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F8E5-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HTMCP:HIV+ Tumor Molecular Characterization Project","workflowStatus":"RELEASED","registrationStatus":"Application","id":"47DE3C27-C0EC-795B-E053-F662850AC379","latestVersionIndicator":"Yes","beginDate":"2017-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-06","modifiedBy":"COOPERM","dateModified":"2017-02-17","changeDescription":"Created for HTMCP Cervical Enrollment form request by K.Wildermuth. mc 2/16/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3008213","version":"1","preferredName":"Day Calculation Value","preferredDefinition":"The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours._The procedure or activity of determining something by mathematical or logical methods._A numerical quantity measured or assigned or computed.","longName":"DAY_CALC_VAL","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3008212","version":"1","preferredName":"Day Calculation Value","preferredDefinition":"The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours.:The procedure or activity of determining something by mathematical or logical methods.:A numerical quantity measured or assigned or computed.","longName":"C25301:C54125:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Day","conceptCode":"C25301","definition":"The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Calculation","conceptCode":"C54125","definition":"The procedure or activity of determining something by mathematical or logical methods.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F1B950C-94C7-3010-E040-BB89AD4368F7","latestVersionIndicator":"Yes","beginDate":"2010-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-08","modifiedBy":"ONEDATA","dateModified":"2010-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F1B950C-94D8-3010-E040-BB89AD4368F7","latestVersionIndicator":"Yes","beginDate":"2010-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-08","modifiedBy":"GDEEN","dateModified":"2023-05-04","changeDescription":"Calculation created for TCGA content requested by Dr. Ari Kahn.  This VD uses a calculation of dividing a value by the number of milliseconds in a day (86,400,000) to result in a number of days, stored as a whole number.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5655968","version":"1","longName":"HTMCP (HIV+Tumor Molecular Characterization Project)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000067","version":"1","longName":"HTMCP","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Days to laboratory procedure","type":"Preferred Question Text","description":"Days to laboratory procedure tumor marker squamous cell carcinoma antigen result","url":null,"context":"NCIP"}],"origin":"HTMCP:HIV+ Tumor Molecular Characterization Project","workflowStatus":"RELEASED","registrationStatus":"Application","id":"47DD8044-9F00-09C5-E053-F662850AB35E","latestVersionIndicator":"Yes","beginDate":"2017-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-06","modifiedBy":"COOPERM","dateModified":"2017-02-17","changeDescription":"Created for Cervical Enrollment form request by K.Wildermuth. mc 2/6/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}